Oxana Beskrovnaya
2022
In 2022, Oxana Beskrovnaya earned a total compensation of $1.5M as Chief Scientific Officer at Dyne Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,023 |
|---|---|
| Option Awards | $426,497 |
| Salary | $450,057 |
| Stock Awards | $428,800 |
| Other | $996 |
| Total | $1,486,373 |
Beskrovnaya received $450.1K in salary, accounting for 30% of the total pay in 2022.
Beskrovnaya also received $180K in non-equity incentive plan, $426.5K in option awards, $428.8K in stock awards and $996 in other compensation.
Rankings
In 2022, Oxana Beskrovnaya's compensation ranked 2,239th out of 5,756 executives tracked by ExecPay. In other words, Beskrovnaya earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,239 out of 5,756 | 61st |
Division Manufacturing | 1,213 out of 3,133 | 61st |
Major group Chemicals And Allied Products | 533 out of 1,419 | 62nd |
Industry group Drugs | 490 out of 1,320 | 63rd |
Industry Pharmaceutical Preparations | 356 out of 966 | 63rd |
Source: SEC filing on April 7, 2023.
Beskrovnaya's colleagues
We found three more compensation records of executives who worked with Oxana Beskrovnaya at Dyne Therapeutics in 2022.